4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-011966
Options or other derivatives
- Chief Medical Officer acquired 655,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hall Jesse Wayne Chief Medical Officer | 2025-05-01 | Grant or award · Restricted Stock Units | +145,500 | 145,500 | D | ||
| Hall Jesse Wayne Chief Medical Officer | 2025-05-01 | Grant or award · Employee Stock Option (right to buy) | +510,000 | 510,000 | D | ||
Loading xslF345X05/form4-05052025_080553.xml…